Here are seven drug and medical device companies that made headlines in the past week.
1. Analysis: Merck cyberattack could cost insurers $275M
Insurers could pay $275 million to cover the insured portion of drugmaker Merck's losses from the NotPetya cyberattack, which struck companies across the globe in June.
2. Dr. Reddy's recalls 500k+ bottles of ulcer drug: 4 things to know
Dr. Reddy's Laboratories recalled more than 500,000 bottles of 10-milligram famotidine tablets Oct. 3.
3. Pfizer rolls out LivingWith app to help patients manage cancer care
Pfizer introduced the program This is Living with Cancer to help cancer patients manage their care, the company announced Oct. 15.
4. Novartis will close US generics plant, eliminating 450 positions
Novartis will eliminate 450 U.S. jobs over the next two years during the gradual closure of its generic drug manufacturing plant in Broomfield, Colo.
5. Amneal Pharma, Impax will merge into US' 5th largest generics maker
Amneal Pharmaceuticals and Impax Laboratories will combine to form the fifth largest generics business in the country, based on revenue.
6. Roche taps drug discovery firm to develop new antibiotic classes
Roche formed a strategic collaboration with the drug discovery company Warp Drive Bio to develop new classes of antibiotics.
7. Merck to lay off 1.8k sales reps: 4 things to know
Merck on Friday shared plans to cut 1,800 sales positions in the U.S.
More articles on supply chain:
Analysis: Biosimilar drugs could cut US healthcare spending by $54B
Health apps should be held to high regulatory scrutiny, researchers say
FDA: 50 medical devices at risk of shortages after Hurricane Maria